Literature DB >> 21191044

Molecular determinants of potent P2X2 antagonism identified by functional analysis, mutagenesis, and homology docking.

Christian Wolf1, Christiane Rosefort, Ghada Fallah, Matthias U Kassack, Alexandra Hamacher, Mandy Bodnar, Haihong Wang, Peter Illes, Achim Kless, Gregor Bahrenberg, Günther Schmalzing, Ralf Hausmann.   

Abstract

P2X2 receptors are members of the ATP-gated P2X family of cation channels, and they participate in neurotransmission in sympathetic ganglia and interneurons. Here, we identified 7,7'-(carbonylbis(imino-3,1-phenylenecarbonylimino-3,1-(4-methyl-phenylene)carbonylimino))bis(1-methoxy-naphthalene-3,6-disulfonic acid) tetrasodium salt (NF770) as a nanomolar-potent competitive P2X2 receptor antagonist within a series of 139 suramin derivatives. Three structural determinants contributed to the inhibition of P2X2 receptors by NF770: 1) a "large urea" structure with two symmetric phenylenecarbonylimino groups; 2) attachment of the naphthalene moiety in position 7,7'; and 3) the specific position of two sulfonic acid groups (3,3'; 6,6') and of one methoxy group (1,1') at the naphthalene moiety. This structure-activity relationship was interpreted using a rat P2X2 homology model based on the crystal structure of the closed zebrafish P2X4 receptor. Docking of the suramin derivatives into the modeled ATP-binding pocket provides a uniform explanation for the observed differences in inhibitory potencies. Changes in the chemical structure that increase the inhibitory potency of the suramin derivatives improved the spatial orientation within the ATP-binding pocket to allow for stronger polar interactions of functional groups with Gly72, Glu167, or Arg290. Gly72 is responsible for the orientation of the methoxy group close to Arg290 or Glu167. Combined mutational and functional analysis confirmed that residues Gly72 and Glu167 are as important for ATP binding as Arg290, the ATP-binding role of which has been shown in previous studies. The in silico prediction of Gly72 and Glu167 as ATP-binding residues strongly supports the validity of our homology docking.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21191044     DOI: 10.1124/mol.110.068700

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  19 in total

Review 1.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

Review 2.  Insights into the channel gating of P2X receptors from structures, dynamics and small molecules.

Authors:  Jin Wang; Ye Yu
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

Review 3.  Medicinal chemistry of adenosine, P2Y and P2X receptors.

Authors:  Kenneth A Jacobson; Christa E Müller
Journal:  Neuropharmacology       Date:  2015-12-12       Impact factor: 5.250

Review 4.  Activation and regulation of purinergic P2X receptor channels.

Authors:  Claudio Coddou; Zonghe Yan; Tomas Obsil; J Pablo Huidobro-Toro; Stanko S Stojilkovic
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

Review 5.  P2X receptors as drug targets.

Authors:  R Alan North; Michael F Jarvis
Journal:  Mol Pharmacol       Date:  2012-12-19       Impact factor: 4.436

6.  Profiling of a suramin-derived compound library at recombinant human P2Y receptors identifies NF272 as a competitive but non-selective P2Y2 receptor antagonist.

Authors:  Nicole Brockmann; Parichat Sureechatchaiyan; David Müller; Tatiana Hennicke; Ralf Hausmann; Gerhard Fritz; Alexandra Hamacher; Matthias U Kassack
Journal:  Purinergic Signal       Date:  2019-07-03       Impact factor: 3.765

7.  Localization of the gate and selectivity filter of the full-length P2X7 receptor.

Authors:  Anja Pippel; Michaela Stolz; Ronja Woltersdorf; Achim Kless; Günther Schmalzing; Fritz Markwardt
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-24       Impact factor: 11.205

Review 8.  Neuromodulation by extracellular ATP and P2X receptors in the CNS.

Authors:  Baljit S Khakh; R Alan North
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

9.  Cysteine scanning mutagenesis (residues Glu52-Gly96) of the human P2X1 receptor for ATP: mapping agonist binding and channel gating.

Authors:  Rebecca C Allsopp; Sam El Ajouz; Ralf Schmid; Richard J Evans
Journal:  J Biol Chem       Date:  2011-06-20       Impact factor: 5.157

Review 10.  Update of P2X receptor properties and their pharmacology: IUPHAR Review 30.

Authors:  Peter Illes; Christa E Müller; Kenneth A Jacobson; Thomas Grutter; Annette Nicke; Samuel J Fountain; Charles Kennedy; Günther Schmalzing; Michael F Jarvis; Stanko S Stojilkovic; Brian F King; Francesco Di Virgilio
Journal:  Br J Pharmacol       Date:  2020-12-21       Impact factor: 9.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.